Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous PRP Intra-ovarian Infusion in Poor Responders
NCT03937661Phase 3Recruiting
- Sponsor
- Genesis Athens Clinic
- Start
- May 2019
- Primary completion
- Jan 2027
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of platelet-rich plasma injection in poor ovarian response (POR) (2 arms), sponsored by Genesis Athens Clinic. Primary endpoints: Number of oocytes retrieved and Anti-Mullerian Hormone levels at 3 months. Started May 2019; status: recruiting.
02
Drugs
platelet-rich plasma injection
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on NCT03937661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03937661.